a case report on somatoform disorder: colorful visual hallucinations
Clicks: 267
ID: 215339
2013
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
63.6
/100
267 views
216 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #30 of 50 articles by views in annals of surgery
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Objectives: To report a case of somatoform disorder (not otherwise specified-NOS).
Methods: The patient was an eight-year-old boy who complained of anxiety and seeing visual hallucinations of colorful shapes. He was administered ant migraine and antiepileptic drugs. However, no changes were observed. Psychotherapy was started, as well as fluoxetine (20 mg per day). Initial assessments included a behavioral interview, charting of daily activities, and recording visual hallucinations with a description of the patient’s emotional and situational condition during the hallucinations.
Results: The patient’s visual hallucinations disappeared completely after two months of treatment.
Discussion: Somatoform disorders may respond well to a combination of behavioral therapy and antidepressant medication.
| Reference Key |
afghah2013iraniana
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Susan Afghah;Morteza gholi Noorikhajavi;Jafar Babapour |
| Journal | annals of surgery |
| Year | 2013 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.